BerandaBIOG-B • STO
add
BioGaia AB
Tutup sebelumnya
kr 122,50
Rentang hari
kr 120,30 - kr 124,00
Rentang tahun
kr 93,20 - kr 124,00
Kapitalisasi pasar
12,07 M SEK
Volume Rata-Rata
211,80 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Tirto.id
14 jam yang lalu
NYSE Content Update: UiPath Celebrates Five-Year Listing Anniversary at NYSE
2,08%
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 440,57 jt | 20,76% |
Biaya operasional | 196,47 jt | 69,09% |
Penghasilan bersih | 98,78 jt | 20,56% |
Margin laba bersih | 22,42 | -0,18% |
Penghasilan per saham | 0,98 | — |
EBITDA | 133,49 jt | -10,77% |
Tarif pajak efektif | 20,07% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 801,31 jt | -34,53% |
Total aset | 1,60 M | -21,45% |
Total liabilitas | 283,59 jt | -8,54% |
Total ekuitas | 1,31 M | — |
Saham yang beredar | 101,16 jt | — |
Harga terhadap nilai buku | 9,43 | — |
Tingkat pengembalian aset | 20,64% | — |
Tingkat pengembalian modal | 24,92% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 98,78 jt | 20,56% |
Kas dari operasi | 83,52 jt | -18,23% |
Kas dari investasi | -452,00 rb | -79,37% |
Kas dari pembiayaan | -6,61 jt | -160,38% |
Perubahan kas bersih | 73,21 jt | -33,07% |
Arus kas bebas | 53,30 jt | 13,33% |
Tentang
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Didirikan
1990
Situs
Karyawan
242
